Beximco Pharmaceuticals Ltd (BXPHARMA):企業の財務・戦略的SWOT分析

◆英語タイトル:Beximco Pharmaceuticals Ltd (BXPHARMA) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15064
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:バングラデシュ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Beximco Pharmaceuticals Ltd (Beximco Pharma) is a manufacturer and exporter of generic medicines and active pharmaceutical ingredients (APIs). The company offers products in the therapeutic areas of allergic disorders, analgesics and antipyretic, anti-infectives, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, intravenous fluids, muscloskeletal, oncology, respiratory, skin care, vitamins and minerals supplement, and others. Beximco Pharma also provides specialized drug delivery systems such as metered dose inhalers, dry powder inhalers, prefilled syringes, lyophilized injectables, oral soluble film, sterile ophthalmics, nasal sprays, and intravenous infusion fluids. The company exports its products to regional markets of the Asia, Africa, the US, and Australia. Beximco Pharma is headquartered in Dhaka, Bangladesh.

Beximco Pharmaceuticals Ltd Key Recent Developments

Jan 31,2019: Beximco Pharmaceuticals: Half Year Results 2018-19
Nov 07,2018: Beximco Pharmaceuticals: Results for the 12 month period ended 30 June 2018
Jan 30,2018: Beximco Pharmaceuticals: Half Year Results 2017-18

This comprehensive SWOT profile of Beximco Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Beximco Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Beximco Pharmaceuticals Ltd – Key Information
Beximco Pharmaceuticals Ltd – Overview
Beximco Pharmaceuticals Ltd – Key Employees
Beximco Pharmaceuticals Ltd – Key Employee Biographies
Beximco Pharmaceuticals Ltd – Key Operational Heads
Beximco Pharmaceuticals Ltd – Major Products and Services
Beximco Pharmaceuticals Ltd – History
Beximco Pharmaceuticals Ltd – Company Statement
Beximco Pharmaceuticals Ltd – Locations And Subsidiaries
Beximco Pharmaceuticals Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Beximco Pharmaceuticals Ltd – Business Description
Beximco Pharmaceuticals Ltd – Corporate Strategy
Beximco Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Beximco Pharmaceuticals Ltd – Strengths
Beximco Pharmaceuticals Ltd – Weaknesses
Beximco Pharmaceuticals Ltd – Opportunities
Beximco Pharmaceuticals Ltd – Threats
Beximco Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Beximco Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Beximco Pharmaceuticals Ltd, Key Information
Beximco Pharmaceuticals Ltd, Key Ratios
Beximco Pharmaceuticals Ltd, Share Data
Beximco Pharmaceuticals Ltd, Major Products and Services
Beximco Pharmaceuticals Ltd, History
Beximco Pharmaceuticals Ltd, Key Employees
Beximco Pharmaceuticals Ltd, Key Employee Biographies
Beximco Pharmaceuticals Ltd, Key Operational Heads
Beximco Pharmaceuticals Ltd, Other Locations
Beximco Pharmaceuticals Ltd, Subsidiaries
Beximco Pharmaceuticals Ltd, Key Manufacturing facilities
Beximco Pharmaceuticals Ltd, Key Competitors
Beximco Pharmaceuticals Ltd, SWOT Analysis
Beximco Pharmaceuticals Ltd, Ratios based on current share price
Beximco Pharmaceuticals Ltd, Annual Ratios
Beximco Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Beximco Pharmaceuticals Ltd, Performance Chart
Beximco Pharmaceuticals Ltd, Ratio Charts

★海外企業調査レポート[Beximco Pharmaceuticals Ltd (BXPHARMA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kering SA:企業の戦略・SWOT・財務情報
    Kering SA - Strategy, SWOT and Corporate Finance Report Summary Kering SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • TelaDoc Inc (TDOC):医療機器:M&Aディール及び事業提携情報
    Summary TelaDoc Inc (Teladoc) is a provider of telehealth services. The company offers short term prescription for amoxicillin, azithromycin, bactrim DS, augmentin, cipro, tessalon perles, flonase nasal spray, pyridium, prednisone and diflucan. It provides telehealth services for cold and flu sympto …
  • Enterprise Products Partners LP (EPD)-石油・ガス分野:企業M&A・提携分析
    Summary Enterprise Products Partners L.P. (Enterprise Products) is a provider of midstream energy services. The company‘s integrated midstream operations include natural gas gathering, treating, processing, transportation and storage; natural gas liquid transportation, fractionation, storage, and im …
  • KEPCO Plant Service & Engineering Co Ltd (051600):企業の財務・戦略的SWOT分析
    KEPCO Plant Service & Engineering Co Ltd (051600) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • E-CO Energi Holding AS:企業の戦略的SWOT分析
    E-CO Energi Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Zeus Co., Ltd. (079370):企業の財務・戦略的SWOT分析
    Zeus Co., Ltd. (079370) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Aptech Ltd (APTECHT):企業の財務・戦略的SWOT分析
    Aptech Ltd (APTECHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Apache Corporation:企業の戦略・SWOT・財務情報
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • One Call Care Management Inc-医療機器分野:企業M&A・提携分析
    Summary One Call Care Management Inc (OCCM), formerly One Call Medical Inc is a healthcare technology provider that offers specialized cost containment services. The company provides diagnostics, dental, transport, complex home care, equipment and physical therapy. It offers value added service and …
  • ASML Holding N.V.:企業の戦略・SWOT・財務分析
    ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report Summary ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • HedgePath Pharmaceuticals Inc (HPPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Hedgepath Pharmaceuticals Inc (Hedgepath), a subsidiary of Mayne Pharma Group Ltd, is a clinical stage biopharmaceutical company that discovers, develops and commercializes novel therapeutics for the treatment of skin, prostrate, and lung cancers. The company is investigating an oral formula …
  • PHX Minerals Inc (PHX):企業の財務・戦略的SWOT分析
    PHX Minerals Inc (PHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Spotlight Innovation Inc (STLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized …
  • Kang Stem Biotech Co Ltd (217730):製薬・医療:M&Aディール及び事業提携情報
    Summary Kang Stem Biotech Co Ltd (Kang Stem Biotech) is a biopharmaceutical company that develops stem cell therapeutic products for the treatment of incurable diseases using umbilical cord blood-derived stem cells. The company’s stem cell therapy products include Furestem-AD for treating subacute a …
  • EnerDel Inc:企業の戦略的SWOT分析
    EnerDel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • GAIL (India) Ltd (GAIL):企業の財務・戦略的SWOT分析
    GAIL (India) Ltd (GAIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Schweizerische Rettungsflugwacht (Rega):企業の戦略的SWOT分析
    Schweizerische Rettungsflugwacht (Rega) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • SMBC Trust Bank Private Banking:企業の戦略・SWOT・財務分析
    SMBC Trust Bank Private Banking - Strategy, SWOT and Corporate Finance Report Summary SMBC Trust Bank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Celldex Therapeutics Inc (CLDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Celldex Therapeutics Inc (Celldex) is a bio-pharmaceutical company that discovers, develops and commercializes targeted immunotherapy technologies and cancer-targeting biologicsfor the treatment of various types of cancers. The company’s developmental pipeline comprises therapeutic antibodie …
  • Mosman Oil & Gas Ltd (MSMN):石油・ガス:M&Aディール及び事業提携情報
    Summary Mosman Oil & Gas Ltd (MOG) is an oil and gas company. The company operates in the exploration, development, and production of oil and gas projects. Its projects include amadeus basin, welch permian basin, blackstone strategic alliance, strawn oil project, and arkoma stacked pay project. MOG’ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆